💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

Neuralink raised $43 million in August but controversy persists for the Musk-led venture

Published 2023-11-27, 02:11 p/m
© Reuters Neuralink raised $43 million in August but controversy persists for the Musk-led venture

Proactive Investors - Neuralink has raised another $43 million in venture capital funds, according to an SEC filing.

The company, an Elon Musk vehicle developing implants that can read users’ brain waves, increased a previous tranche to $323 million from $280 million in August, according to the filing.

Some 32 investors participated, led by Peter Thiel’s Founders Fund.

Meanwhile, four members of the US House of Representatives are calling on the SEC to investigate the company over Elon Musk's statements regarding the welfare of animals used in the company’s experiments.

The SEC alleges that Musk made misleading claims about the deaths of 12 macaque monkeys used in research for the brain-chip interface company.

That followed a report from WIRED, which described animal welfare concerns at a primate center in California between 2018 and 2020.

Neuralink received FDA approval for human clinical trials in May, and in June the company was valued at roughly $5 billion, according to reporting from Reuters.

Read more on Proactive Investors CA

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.